JP5491001B2 - 超音波システム - Google Patents
超音波システム Download PDFInfo
- Publication number
- JP5491001B2 JP5491001B2 JP2008118048A JP2008118048A JP5491001B2 JP 5491001 B2 JP5491001 B2 JP 5491001B2 JP 2008118048 A JP2008118048 A JP 2008118048A JP 2008118048 A JP2008118048 A JP 2008118048A JP 5491001 B2 JP5491001 B2 JP 5491001B2
- Authority
- JP
- Japan
- Prior art keywords
- viability
- test
- compartment
- compartments
- planning module
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002604 ultrasonography Methods 0.000 title claims description 38
- 238000012360 testing method Methods 0.000 claims description 74
- 210000005240 left ventricle Anatomy 0.000 claims description 72
- 238000009125 cardiac resynchronization therapy Methods 0.000 claims description 68
- 230000035899 viability Effects 0.000 claims description 56
- 238000000034 method Methods 0.000 claims description 41
- 230000006870 function Effects 0.000 claims description 34
- 230000002861 ventricular Effects 0.000 claims description 8
- 230000033001 locomotion Effects 0.000 claims description 7
- 239000003086 colorant Substances 0.000 claims description 2
- 244000309464 bull Species 0.000 claims 2
- 238000005192 partition Methods 0.000 description 55
- 210000001519 tissue Anatomy 0.000 description 8
- 238000002513 implantation Methods 0.000 description 6
- 238000003384 imaging method Methods 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 230000000007 visual effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 238000010176 18-FDG-positron emission tomography Methods 0.000 description 3
- ZCXUVYAZINUVJD-AHXZWLDOSA-N 2-deoxy-2-((18)F)fluoro-alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H]([18F])[C@@H](O)[C@@H]1O ZCXUVYAZINUVJD-AHXZWLDOSA-N 0.000 description 3
- 238000013184 cardiac magnetic resonance imaging Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000002592 echocardiography Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 238000009206 nuclear medicine Methods 0.000 description 3
- JRWZLRBJNMZMFE-UHFFFAOYSA-N Dobutamine Chemical compound C=1C=C(O)C(O)=CC=1CCNC(C)CCC1=CC=C(O)C=C1 JRWZLRBJNMZMFE-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 238000002059 diagnostic imaging Methods 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 229960001089 dobutamine Drugs 0.000 description 2
- 238000011990 functional testing Methods 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- 210000005003 heart tissue Anatomy 0.000 description 2
- 238000002595 magnetic resonance imaging Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 238000002603 single-photon emission computed tomography Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000012285 ultrasound imaging Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000006406 biphasic response Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000002169 extracardiac Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 230000003483 hypokinetic effect Effects 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 210000005241 right ventricle Anatomy 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
- A61B34/10—Computer-aided planning, simulation or modelling of surgical operations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
- A61B6/503—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
- A61B8/0883—Detecting organic movements or changes, e.g. tumours, cysts, swellings for diagnosis of the heart
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medical Informatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Radiology & Medical Imaging (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Electrotherapy Devices (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Description
12 プローブ
14 一体型表示器
24 外部装置
26 網
28 ユーザ・インタフェイス
100 超音波システム
102 送波器
104 トランスデューサ素子
106 プローブ
108 受波器
110 ビームフォーマ
112 RFプロセッサ
114 RF/IQバッファ
116 プロセッサ
118 表示器
120 利用者入力
122 メモリ
124 CRT誘導配置計画モジュール
126 第一の非同期性検査
128 第二の非同期性検査
130 マイクロフォン
132 第一の生存力検査
134 第二の生存力検査
136 遠隔装置
138 第三の非同期性検査
140 第三の生存力検査
142 網
144 第一の局所機能検査
146 第二の局所機能検査
148 第三の局所機能検査
200 CRT誘導配置ツールを起動する
202 非同期性検査を指定する
204 生存力検査又は局所機能検査を指定する
206 区画(1又は複数)に関連付けされる非同期性データ、及び生存力データ又は局所機能データを検索する
208 ピーク速度までの最大時間遅延によってLV区画を識別する
210 LV区画は最小レベルの生存力又は機能を有するか?
212 LV区画は最小レベルの遅延を有するか?
214 LV区画を最適未満区画として識別する
216 LV区画を最適な又は好ましい区画として識別する
218 他のLV区画を検討するか?
220 LV区画をピーク速度までの時間遅延が次に最大のものによって識別する
222 LV区画を回避すべき区画として識別する
224 各々の区画について勧告を決定する
226 視覚的表現を準備する
230 ブルズ・アイ・プロット
231 第一の区画
232 第二の区画
233 第三の区画
234 第四の区画
235 第五の区画
236 第六の区画
237 第七の区画
238 第八の区画
239 第九の区画
240 第十の区画
241 第十一の区画
242 第十二の区画
243 第十三の区画
244 第十四の区画
245 第十五の区画
246 第十六の区画
250 ブルズ・アイ・プロット
252 第一の色
254 第二の色
256 第三の色
270 3Dサーフェス・モデル
272 第三の区画
274 第四の区画
276 第九の区画
278 第十の区画
280 第十四の区画
282 第十五の区画
284 第一のパターン
286 第二のパターン
288 凡例
290 勧告
292 指標を表示する
Claims (6)
- 患者の左室の各区画(231〜246)に関連付けされており、少なくとも第一の非同期性検査(126)と、領域が機能していること又は前記領域が機能している程度を決定することを含む第一の局所機能検査(144)及び前記左室の壁運動に基づく第一の生存力検査(132)とのうちの少なくとも一方を含む患者検査データを記憶するメモリ(122)と、
前記区画(231〜246)の各々について前記患者検査データの少なくとも一部を比較し、最小レベルの生存力を上回り、ピーク速度までの最小時間遅延を上回る複数の左室区画を特定し、前記特定された複数の区画の優先順位を付ける心再同期療法誘導配置計画モジュール(124)と、
前記区画の各々についての前記患者検査データの前記少なくとも一部の前記比較に基づいて、心再同期療法処置時の前記患者の左室の前記区画(231〜246)の一つの内部への左室誘導の配置のための少なくとも1箇所の位置を示す出力装置と
を備えた超音波システム(100)。 - 前記出力装置は、前記区画(231〜246)の少なくとも一つと前記少なくとも1箇所の位置との間の関連性を表示するリスト、チャート、ブルズ・アイ・プロット(250)及び3Dモデル(270)の少なくとも一つを表示する表示器(118)を含んでいる、請求項1に記載の超音波システム(100)。
- 前記第一の非同期性検査(126)は、前記区画(231〜246)の各々をピーク速度までの時間遅延と関連付けるタイミング・データを含んでおり、前記心再同期療法誘導配置計画モジュール(124)は、ピーク速度までの最大時間遅延を有する前記区画(231〜246)の範囲内から第一の区画を識別し、前記心再同期療法誘導配置計画モジュールは、前記第一の区画が前記第一の生存力検査(132)及び前記第一の局所機能検査(126)にそれぞれ基づく最小レベルの生存力及び最小レベルの機能の少なくとも一方を上回るか否かを判定する、請求項1に記載の超音波システム(100)。
- 前記心再同期療法誘導配置計画モジュール(124)は、前記区画の各々を、好ましい位置、最適未満位置及び回避すべき位置の一つを含むグループと関連付け、前記出力装置は、前記好ましい位置にある前記区画(231〜246)を第一の指標により識別し、前記最適未満位置にある前記区画(231〜246)を第二の指標により識別し、前記回避すべき位置にある前記区画(231〜246)を第三の指標により識別し、前記第一、第二及び第三の指標は互いに対して異なっている、請求項1に記載の超音波システム(100)。
- 前記心再同期療法誘導配置計画モジュール(124)は、ピーク速度までの最大時間遅延を有する第一の区画を識別することをさらに含んでおり、前記心再同期療法誘導配置計画モジュール(124)は、前記第一の区画の生存力レベルを最小レベルの生存力とさらに比較し(210)、前記出力装置は、前記第一の区画が前記最小レベルの生存力を上回るときに前記第一の区画(216)の内部に前記左室誘導を配置する勧告を出力し、前記第一の区画が前記最小レベルに満たない生存力を有するときに前記第一の区画(222)を回避する勧告を出力することをさらに含んでいる、請求項1に記載の超音波システム(100)。
- 前記出力装置は、前記左室に基づくブルズ・アイ・プロット(250)を表示する表示器(118)を含んでおり、左室誘導の配置の前記少なくとも1箇所の位置は、前記区画を前記ブルズ・アイ・プロット(250)に異なる色(252、254、256)、異なる濃淡度、及び異なるパターン(284、256)の一つとして示すことを含んでいる、請求項1に記載の超音波システム(100)。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/801,271 US20080281195A1 (en) | 2007-05-09 | 2007-05-09 | System and method for planning LV lead placement for cardiac resynchronization therapy |
US11/801,271 | 2007-05-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008289873A JP2008289873A (ja) | 2008-12-04 |
JP5491001B2 true JP5491001B2 (ja) | 2014-05-14 |
Family
ID=39970158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008118048A Active JP5491001B2 (ja) | 2007-05-09 | 2008-04-30 | 超音波システム |
Country Status (2)
Country | Link |
---|---|
US (1) | US20080281195A1 (ja) |
JP (1) | JP5491001B2 (ja) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102724918A (zh) * | 2010-01-29 | 2012-10-10 | 株式会社日立医疗器械 | 超声波诊断装置及其测量点追踪方法 |
US9265951B2 (en) | 2010-02-12 | 2016-02-23 | The Brigham And Women's Hospital | System and method for automated adjustment of cardiac resynchronization therapy control parameters |
JP5660849B2 (ja) * | 2010-10-26 | 2015-01-28 | ジーイー・メディカル・システムズ・グローバル・テクノロジー・カンパニー・エルエルシー | 画像処理装置およびプログラム並びに画像診断装置 |
RU2594811C2 (ru) | 2011-03-02 | 2016-08-20 | Конинклейке Филипс Н.В. | Визуализация для навигационного указания |
US9510763B2 (en) | 2011-05-03 | 2016-12-06 | Medtronic, Inc. | Assessing intra-cardiac activation patterns and electrical dyssynchrony |
US20130072790A1 (en) * | 2011-09-19 | 2013-03-21 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Selection and optimization for cardiac resynchronization therapy |
JP6113734B2 (ja) * | 2011-09-29 | 2017-04-12 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | 状況によって可変な制御パネルを持つ超音波診断撮像システム |
US20150206302A1 (en) * | 2012-08-30 | 2015-07-23 | Emory University | Systems, methods and computer readable storage media storing instructions for integrating fluoroscopy venogram and myocardial images |
US9278219B2 (en) | 2013-03-15 | 2016-03-08 | Medtronic, Inc. | Closed loop optimization of control parameters during cardiac pacing |
US10064567B2 (en) | 2013-04-30 | 2018-09-04 | Medtronic, Inc. | Systems, methods, and interfaces for identifying optimal electrical vectors |
US9931048B2 (en) | 2013-04-30 | 2018-04-03 | Medtronic, Inc. | Systems, methods, and interfaces for identifying effective electrodes |
US9474457B2 (en) | 2013-06-12 | 2016-10-25 | Medtronic, Inc. | Metrics of electrical dyssynchrony and electrical activation patterns from surface ECG electrodes |
US9877789B2 (en) | 2013-06-12 | 2018-01-30 | Medtronic, Inc. | Implantable electrode location selection |
US10251555B2 (en) | 2013-06-12 | 2019-04-09 | Medtronic, Inc. | Implantable electrode location selection |
US9282907B2 (en) | 2013-07-23 | 2016-03-15 | Medtronic, Inc. | Identification of healthy versus unhealthy substrate for pacing from a multipolar lead |
US9278220B2 (en) | 2013-07-23 | 2016-03-08 | Medtronic, Inc. | Identification of healthy versus unhealthy substrate for pacing from a multipolar lead |
US9265954B2 (en) | 2013-07-26 | 2016-02-23 | Medtronic, Inc. | Method and system for improved estimation of time of left ventricular pacing with respect to intrinsic right ventricular activation in cardiac resynchronization therapy |
US9265955B2 (en) | 2013-07-26 | 2016-02-23 | Medtronic, Inc. | Method and system for improved estimation of time of left ventricular pacing with respect to intrinsic right ventricular activation in cardiac resynchronization therapy |
US9345550B2 (en) * | 2013-10-31 | 2016-05-24 | Pacesetter, Inc. | Method and system for characterizing stimulus sites and providing implant guidance |
US9320446B2 (en) | 2013-12-09 | 2016-04-26 | Medtronic, Inc. | Bioelectric sensor device and methods |
US9993172B2 (en) | 2013-12-09 | 2018-06-12 | Medtronic, Inc. | Noninvasive cardiac therapy evaluation |
US9776009B2 (en) | 2014-03-20 | 2017-10-03 | Medtronic, Inc. | Non-invasive detection of phrenic nerve stimulation |
US9591982B2 (en) | 2014-07-31 | 2017-03-14 | Medtronic, Inc. | Systems and methods for evaluating cardiac therapy |
US9764143B2 (en) | 2014-08-15 | 2017-09-19 | Medtronic, Inc. | Systems and methods for configuration of interventricular interval |
US9707400B2 (en) | 2014-08-15 | 2017-07-18 | Medtronic, Inc. | Systems, methods, and interfaces for configuring cardiac therapy |
US9586052B2 (en) | 2014-08-15 | 2017-03-07 | Medtronic, Inc. | Systems and methods for evaluating cardiac therapy |
US9586050B2 (en) | 2014-08-15 | 2017-03-07 | Medtronic, Inc. | Systems and methods for configuration of atrioventricular interval |
US11253178B2 (en) | 2015-01-29 | 2022-02-22 | Medtronic, Inc. | Noninvasive assessment of cardiac resynchronization therapy |
US11219769B2 (en) | 2016-02-26 | 2022-01-11 | Medtronic, Inc. | Noninvasive methods and systems of determining the extent of tissue capture from cardiac pacing |
US10780279B2 (en) | 2016-02-26 | 2020-09-22 | Medtronic, Inc. | Methods and systems of optimizing right ventricular only pacing for patients with respect to an atrial event and left ventricular event |
US10532213B2 (en) | 2017-03-03 | 2020-01-14 | Medtronic, Inc. | Criteria for determination of local tissue latency near pacing electrode |
US10987517B2 (en) | 2017-03-15 | 2021-04-27 | Medtronic, Inc. | Detection of noise signals in cardiac signals |
CN110996784B (zh) | 2017-07-28 | 2023-05-30 | 美敦力公司 | 生成激动时间 |
WO2019023478A1 (en) | 2017-07-28 | 2019-01-31 | Medtronic, Inc. | SELECTION OF CARDIAC REVOLUTION |
US10799703B2 (en) | 2017-12-22 | 2020-10-13 | Medtronic, Inc. | Evaluation of his bundle pacing therapy |
US11419539B2 (en) | 2017-12-22 | 2022-08-23 | Regents Of The University Of Minnesota | QRS onset and offset times and cycle selection using anterior and posterior electrode signals |
US10786167B2 (en) | 2017-12-22 | 2020-09-29 | Medtronic, Inc. | Ectopic beat-compensated electrical heterogeneity information |
US10492705B2 (en) | 2017-12-22 | 2019-12-03 | Regents Of The University Of Minnesota | Anterior and posterior electrode signals |
US10433746B2 (en) | 2017-12-22 | 2019-10-08 | Regents Of The University Of Minnesota | Systems and methods for anterior and posterior electrode signal analysis |
US10617318B2 (en) | 2018-02-27 | 2020-04-14 | Medtronic, Inc. | Mapping electrical activity on a model heart |
US10668290B2 (en) | 2018-03-01 | 2020-06-02 | Medtronic, Inc. | Delivery of pacing therapy by a cardiac pacing device |
US10918870B2 (en) | 2018-03-07 | 2021-02-16 | Medtronic, Inc. | Atrial lead placement for treatment of atrial dyssynchrony |
US10780281B2 (en) | 2018-03-23 | 2020-09-22 | Medtronic, Inc. | Evaluation of ventricle from atrium pacing therapy |
WO2019191602A1 (en) | 2018-03-29 | 2019-10-03 | Medtronic, Inc. | Left ventricular assist device adjustment and evaluation |
US10940321B2 (en) | 2018-06-01 | 2021-03-09 | Medtronic, Inc. | Systems, methods, and interfaces for use in cardiac evaluation |
US11304641B2 (en) | 2018-06-01 | 2022-04-19 | Medtronic, Inc. | Systems, methods, and interfaces for use in cardiac evaluation |
US11547858B2 (en) | 2019-03-29 | 2023-01-10 | Medtronic, Inc. | Systems, methods, and devices for adaptive cardiac therapy |
US11697025B2 (en) | 2019-03-29 | 2023-07-11 | Medtronic, Inc. | Cardiac conduction system capture |
US11497431B2 (en) | 2019-10-09 | 2022-11-15 | Medtronic, Inc. | Systems and methods for configuring cardiac therapy |
US11642533B2 (en) | 2019-11-04 | 2023-05-09 | Medtronic, Inc. | Systems and methods for evaluating cardiac therapy |
US11813464B2 (en) | 2020-07-31 | 2023-11-14 | Medtronic, Inc. | Cardiac conduction system evaluation |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6149578A (en) * | 1999-02-04 | 2000-11-21 | My-Tech, Inc. | Piston-action intra-aortic coronary assist device |
US20020124855A1 (en) * | 2001-03-12 | 2002-09-12 | Chachques Juan C. | Method of providing a dynamic cellular cardiac support |
US6579240B2 (en) * | 2001-06-12 | 2003-06-17 | Ge Medical Systems Global Technology Company, Llc | Ultrasound display of selected movement parameter values |
EP1527422B1 (en) * | 2002-06-28 | 2019-05-22 | Koninklijke Philips N.V. | Image processing method for displaying information relating to wall motions of a deformable 3-d object |
US6978184B1 (en) * | 2002-07-29 | 2005-12-20 | Marcus Frank I | Optimization method for cardiac resynchronization therapy |
US7343196B2 (en) * | 2003-05-09 | 2008-03-11 | Ge Medical Systems Global Technology Company Llc | Cardiac CT system and method for planning and treatment of biventricular pacing using epicardial lead |
US7563229B2 (en) * | 2003-06-11 | 2009-07-21 | Ge Medical Systems Global Technology Company Llc | Method and apparatus for automatically measuring delay of tissue motion and deformation |
-
2007
- 2007-05-09 US US11/801,271 patent/US20080281195A1/en not_active Abandoned
-
2008
- 2008-04-30 JP JP2008118048A patent/JP5491001B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP2008289873A (ja) | 2008-12-04 |
US20080281195A1 (en) | 2008-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5491001B2 (ja) | 超音波システム | |
CN106659474B (zh) | 用于自诊断和远程诊断的超声诊断设备以及操作超声诊断设备的方法 | |
CN105263420B (zh) | 3d超声成像系统 | |
CN101066210B (zh) | 超声系统中显示信息的方法 | |
JP6640922B2 (ja) | 超音波診断装置及び画像処理装置 | |
JP4795939B2 (ja) | 知識ベースの診断用イメージングのための方法及びシステム | |
CN107072635B (zh) | 用于中间用户反馈的多跳超声心动图采集的质量度量 | |
US10524765B2 (en) | Refinement of an anatomical model using ultrasound | |
US8480583B2 (en) | Methods and apparatus for 4D data acquisition and analysis in an ultrasound protocol examination | |
US10799215B2 (en) | Ultrasound systems, methods and apparatus for associating detection information of the same | |
EP3518771B1 (en) | Method and system for enhanced visualization and selection of a representative ultrasound image by automatically detecting b lines and scoring images of an ultrasound scan | |
CN111629670B (zh) | 用于超声系统的回波窗口伪影分类和视觉指示符 | |
US20100249589A1 (en) | System and method for functional ultrasound imaging | |
US20120154400A1 (en) | Method of reducing noise in a volume-rendered image | |
JP2013524984A (ja) | 診断ecgにおける心筋梗塞サイズの可視化 | |
KR20150107214A (ko) | 초음파 진단 장치 및 그에 따른 초음파 영상의 디스플레이 방법 | |
US20160038125A1 (en) | Guided semiautomatic alignment of ultrasound volumes | |
US20110275908A1 (en) | Method for analysing medical data | |
US20140153358A1 (en) | Medical imaging system and method for providing imaging assitance | |
US11399803B2 (en) | Ultrasound imaging system and method | |
AU2017286613A1 (en) | Image-based diagnostic systems | |
JP2022545219A (ja) | 超音波ガイダンスダイナミックモード切り替え | |
JP5630967B2 (ja) | 画像処理装置及びその制御方法 | |
CN115334975A (zh) | 用于对心外膜脂肪组织进行成像和测量的系统和方法 | |
JP7427002B2 (ja) | フレームのインデックス付け及び画像レビューのためのシステム及び方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20110125 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110419 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120417 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121211 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130123 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130611 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130709 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20131119 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140109 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140204 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140227 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5491001 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |